Physician profile
Mitchell L Oliver
NPI 1922111640
$1,476.30
in general payments reported to CMS, 2019-2025
20 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $125 · 2021: $101 · 2022: $79.69 · 2023: $241 · 2024: $215 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762 · Gift: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.93 |
| Gift | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $308.79 | 2020-2024 | Sutab |
| Abbvie INC. | $277.45 | 2021-2025 | |
| Boston Scientific Corporation | $227.91 | 2023-2025 | Resolution 360 Clip, Exalt Model D |
| Novo Nordisk INC | $121.55 | 2019-2023 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.82 | 2024 | Xifaxan |
| Gilead Sciences, INC. | $69.68 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $61.91 | 2019 | |
| Merck Sharp & Dohme LLC | $43.31 | 2019-2020 | |
| Pfizer INC. | $38.60 | 2019 | |
| Shire North American Group INC | $32.52 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.22 | 2019 | |
| Janssen Biotech, INC. | $30.79 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $23.32 | 2020 | |
| Amgen INC. | $20.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.92 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.25 | 2019 | |
| Allergan, INC. | $16.40 | 2019 | |
| Conmed Corporation | $15.74 | 2023 | Conmed Generators |
| Kowa Pharmaceuticals America, INC. | $15.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.